4//SEC Filing
EMANUELE ROBERT MARTIN 4
Accession 0001209191-13-029864
CIK 0001160308other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:14 PM ET
Size
5.5 KB
Accession
0001209191-13-029864
Insider Transaction Report
Form 4
EMANUELE ROBERT MARTIN
Senior VP, Development
Transactions
- Award
Common Stock
2013-05-30+52,543→ 294,598 total
Footnotes (1)
- [F1]The Reporting Person became entitled to receive the shares of the Issuer's common stock reported in this Form 4 on May 30, 2013 pursuant to an earn-out provision in the merger agreement pursuant to which the Issuer acquired SynthRx, Inc. on April 8, 2011. The merger agreement provided that the former stockholders of SynthRx, including the Reporting Person, would receive, for no additional consideration, additional shares of the Issuer's common stock in connection with achievement of specified development milestones related to SynthRx's lead product candidate. The Reporting Person's right to receive such milestone shares, including the shares reported in this Form 4, became fixed and irrevocable on April 8, 2011, the effective date of the merger.
Documents
Issuer
Mast Therapeutics, Inc.
CIK 0001160308
Entity typeother
Related Parties
1- filerCIK 0001184991
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:14 PM ET
- Size
- 5.5 KB